NPM1 and leukemia: An expansion of testing into other types of leukaemia led to a trial enrolling 591 AML patients in 1999 with Falini and colleagues demonstrating a high proportion of cases showed cytoplasmic localisation of NPM1 in AML, the primary cause of which was identified as mutations in exon 12 of NPM1 [45].